Brief Title
Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
Official Title
Comparison of Effectiveness and Safety of Thyroidectomy for Thyroid Carcinoma in Patients Undergo Endoscopic Surgery and Those Receive Conversion
Brief Summary
Endoscopic thyroidectomy has been used to treat thyroid diseases in China. However, whether this technique is rational to treat thyroid carcinoma is still in controversy. The diagnosis of thyroid carcinoma is predominantly made according to intra-operative frozen section pathological examination in China. In this research, the investigators want to compare clinical index (blood loss, operation duration, number of lymph nodes dissected, complication rates, etc) between patients underwent endoscopic thyroidectomy ( total thyroidectomy) and those underwent conversion to open procedure. The investigators want to evaluate the technical feasibility of endoscopic thyroidectomy for treating thyroid carcinoma.
Detailed Description
intra-operative diagnosis of thyroid carcinoma is usually considered the indication of conversion to open surgery. with accumulation of experience of endoscopic thyroidectomy, the investigators want to evaluate the technical feasibility, completeness and safety of endoscopic thyroidectomy.
Study Type
Interventional
Primary Outcome
to evaluate the completeness of thyroid resection and clearance of lymph nodes in the central compartment, and to observe the complications such as RLN palsy and hypocalcemia
Condition
Thyroid Carcinoma
Intervention
thyroidectomy
Study Arms / Comparison Groups
conversion
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
60
Start Date
January 2010
Completion Date
June 2012
Primary Completion Date
December 2011
Eligibility Criteria
Inclusion Criteria: - lesion diameter less than 1 cm by ultrasound Exclusion Criteria: - frozen section diagnosis indicates benign lesion
Gender
All
Ages
18 Years - 45 Years
Accepts Healthy Volunteers
No
Contacts
Ming QIU, Dr., 8621-81885801, [email protected]
Location Countries
China
Location Countries
China
Administrative Informations
NCT ID
NCT00993837
Organization ID
SMMU-2-2009-3
Study Sponsor
Second Military Medical University
Study Sponsor
Ming QIU, Dr., Study Chair, Changzheng Hospital affliated to SMMU
Verification Date
October 2009